Ved ordination af CIALIS, bør den ordinerende læge foretage en omhyggelig individuel benefit/ risk- vurdering.
There is limited clinical data on the safety of CIALIS in patients with severe hepatic impairment (Child-Pugh Class C); if prescribed, a careful individual benefit/ risk evaluation should be undertaken by the prescribing physician.